Relevant clinical outcomes in probable vascular dementia and Alzheimer's disease with cerebrovascular disease. (Q53251375)

12 May 2018

title

Relevant clinical outcomes in probable vascular dementia and Alzheimer's disease with cerebrovascular disease. (English)

1 reference

12 May 2018

1 reference

1 reference

12 May 2018

author name string

Sean Lilienfeld

series ordinal

1 reference

12 May 2018

publication date

1 November 2002

1 reference

12 May 2018

Journal of the Neurological Sciences

published in

1 reference

12 May 2018

volume

203-204

1 reference

12 May 2018

page(s)

41-48

1 reference

12 May 2018

Propentofylline in the treatment of Alzheimer's disease and vascular dementia: a review of phase III trials

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Prevalence and outcomes of vascular cognitive impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

The diagnosis of "mixed" dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Is vascular dementia really Alzheimer's disease or mixed dementia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

A new rating scale for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Bedside assessment of frontal degeneration: distinguishing Alzheimer's disease from non-Alzheimer's cortical dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Bedside assessment of executive cognitive impairment: the executive interview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

A new clinical scale for the staging of dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Assessing the severity of dementia. Patient and caregiver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Behavioral disturbances in geropsychiatric inpatients across dementia types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Vascular dementia versus dementia of Alzheimer's type: do they have differential effects on caregivers' burden?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Anxiety, depression and psychosis in vascular dementia: prevalence and associations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Behavioral differences between white matter lacunar dementia and Alzheimer's disease: a comparison on the neuropsychiatric inventory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

The screen for caregiver burden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Outcome measures in Alzheimer's disease: do they go far enough?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Burden: a review of measures used among caregivers of individuals with dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Course characteristics in the differentiation of dementia of the Alzheimer type and multi-infarct dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Survival in Alzheimer's disease and vascular dementias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

A controlled study of survival with dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Survival in presenile Alzheimer's and multi-infarct dementias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900259-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(02)00259-9

1 reference

12 May 2018

1 reference

12 May 2018